Cargando…
Tofacitinib treatment aggravates Staphylococcus aureus septic arthritis, but attenuates sepsis and enterotoxin induced shock in mice
Tofacitinib, a janus kinase inhibitor, is a novel immunosuppressive drug for treatment of rheumatoid arthritis (RA). Septic arthritis (SA) and sepsis caused by Staphylococcus aureus (S. aureus), for which RA patients are at risk, are infections with high mortality. The aim of this study was to inves...
Autores principales: | Jarneborn, Anders, Mohammad, Majd, Engdahl, Cecilia, Hu, Zhicheng, Na, Manli, Ali, Abukar, Jin, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331611/ https://www.ncbi.nlm.nih.gov/pubmed/32616791 http://dx.doi.org/10.1038/s41598-020-67928-0 |
Ejemplares similares
-
Deficiency of the Complement Component 3 but Not Factor B Aggravates Staphylococcus aureus Septic Arthritis in Mice
por: Na, Manli, et al.
Publicado: (2016) -
The YIN and YANG of lipoproteins in developing and preventing infectious arthritis by Staphylococcus aureus
por: Mohammad, Majd, et al.
Publicado: (2019) -
The role of Staphylococcus aureus lipoproteins in hematogenous septic arthritis
por: Mohammad, Majd, et al.
Publicado: (2020) -
The Expression of von Willebrand Factor-Binding Protein Determines Joint-Invading Capacity of Staphylococcus aureus, a Core Mechanism of Septic Arthritis
por: Na, Manli, et al.
Publicado: (2020) -
The Impact of Aging and Toll-like Receptor 2 Deficiency on the Clinical Outcomes of Staphylococcus aureus Bacteremia
por: Hu, Zhicheng, et al.
Publicado: (2023)